Movement Disorders

Movement disorders are a group of nervous system disorders that increase or decrease voluntary or involuntary movements. Here is the latest research on genetic and environmental factors, as well as mechanisms that underlie movement disorders.

August 3, 2020

Neuroinflammation and histone H3 citrullination are increased in X-linked Dystonia Parkinsonism post-mortem prefrontal cortex

Neurobiology of Disease
Tiziana PetrozzielloGhazaleh Sadri-Vakili
August 3, 2020

Atypical brain MRI in neurological Wilson disease

Parkinsonism & Related Disorders
Jong Hyeon AhnJinyoung Youn
August 1, 2020
Open Access

Body Concept and Quality of Life in Patients with Idiopathic Dystonia

Brain Sciences
Lejla ParackaJoachim K Krauss
July 31, 2020

Understanding the relationship between freezing of gait and other progressive supranuclear palsy features

Parkinsonism & Related Disorders
Saba RezvanianBenzi Kluger
August 2, 2020

Hyperventilation Increases the Randomness of Ocular Palatal Tremor Waveforms

The Cerebellum
Wanchat TheeranaewAasef G Shaikh
August 2, 2020

Modulating Disease-Relevant Tau Oligomeric Strains by Small Molecules

The Journal of Biological Chemistry
Filippa Lo CascioRakez Kayed
August 1, 2020

Trait perspective-taking and need for cognition in the formation of stereotypes about people who stutter

Journal of Fluency Disorders
Maxim BaryshevtsevMatthew McGlone
August 1, 2020

Circadian alterations in patients with neurodegenerative diseases: Neuropathological basis of underlying network mechanisms

Neurobiology of Disease
Karim Fifel, Aleksandar Videnovic
August 2, 2020

The Neurodevelopmental Spectrum of Synaptic Vesicle Cycling Disorders

Journal of Neurochemistry
Abinayah JohnKate Baker
August 1, 2020

Paraventricular hypothalamus mediates diurnal rhythm of metabolism

Nature Communications
Eun Ran KimQingchun Tong
August 1, 2020

Quality of life outcomes after globus pallidus internus deep brain stimulation in idiopathic or inherited isolated dystonia: a meta-analysis

Journal of Neurology, Neurosurgery, and Psychiatry
Takashi TsuboiAdolfo Ramirez-Zamora
July 31, 2020
Open Access

BCAS1-positive immature oligodendrocytes are affected by the α-synuclein-induced pathology of multiple system atrophy

Acta Neuropathologica Communications
Seiji KajiRyosuke Takahashi
July 31, 2020
Case Report

Therapeutic effectiveness of thalidomide in a patient with treatment-resistant restless legs syndrome

Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine
Aaro V SalminenJuliane Winkelmann
July 31, 2020

Autoimmune Encephalitis in Children: An Update

Indian Pediatrics
Divyani GargSuvasini Sharma
August 3, 2020

Impact of circadian and diurnal rhythms on cellular metabolic function and neurodegenerative diseases

International Review of Neurobiology
S Kendall Smith, Erik S Musiek
August 1, 2020

Botulinum toxin therapy in the SARS-CoV-2 pandemic: patient perceptions from a German cohort

Journal of Neural Transmission
Dirk Dressler, Fereshte Adib Saberi
August 1, 2020
Open Access

Elevated Percentage of CD3+ T-Cells and CD4+ /CD8+ Ratios in Multiple System Atrophy Patients

Frontiers in Neurology
Bei CaoHuifang Shang

Sign up to follow this feed and discover related papers.

Related Feeds


Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.


ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

Alpha-Synuclein Structure and Function

α-Synuclein is an integral component of Lewy bodies which are comprised of protein clumps and are a pathological hallmark of Parkinson’s disease. Here is the latest research on α-Synuclein structure and function.

Antisense Oligonucleotide - Therapies For ALS

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.

Astrocytes & Huntington’s Disease

Astrocytes are abundant within the central nervous system and their dysfunction has been thought to be an important contributor to some neurodegenerative diseases, in particular Huntington’s disease. Damage to these cells may make neurons more susceptible to degeneration. Here is the latest research on astrocytes and Huntington’s disease.

Astrocytes and Neurodegeneration

Astrocytes are important for the health and function of the central nervous system. When these cells stop functioning properly, either through gain of function or loss of homeostatic controls, neurodegenerative diseases can occur. Here is the latest research on astrocytes and neurodegeneration.

© 2020 Meta ULC. All rights reserved